1. Home
  2. GDRX vs MPLT Comparison

GDRX vs MPLT Comparison

Compare GDRX & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoodRx Holdings Inc.

GDRX

GoodRx Holdings Inc.

HOLD

Current Price

$2.52

Market Cap

868.9M

Sector

Technology

ML Signal

HOLD

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$18.32

Market Cap

772.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GDRX
MPLT
Founded
2011
2018
Country
United States
United States
Employees
738
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
868.9M
772.7M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
GDRX
MPLT
Price
$2.52
$18.32
Analyst Decision
Buy
Strong Buy
Analyst Count
10
4
Target Price
$4.78
$31.00
AVG Volume (30 Days)
2.1M
171.4K
Earning Date
02-26-2026
02-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$800,651,000.00
N/A
Revenue This Year
$2.30
N/A
Revenue Next Year
$2.63
N/A
P/E Ratio
$29.60
N/A
Revenue Growth
1.30
N/A
52 Week Low
$2.47
$12.24
52 Week High
$5.81
$21.55

Technical Indicators

Market Signals
Indicator
GDRX
MPLT
Relative Strength Index (RSI) 31.70 N/A
Support Level $2.47 N/A
Resistance Level $2.63 N/A
Average True Range (ATR) 0.11 0.00
MACD -0.02 0.00
Stochastic Oscillator 11.23 0.00

Price Performance

Historical Comparison
GDRX
MPLT

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.

Share on Social Networks: